Aigen Investment Management »

Heron Therapeutics shares owned by Aigen Investment Management

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Aigen Investment Management from 13F filings

Historical chart of Aigen Investment Management investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Aigen Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Aigen Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $17k 13k 1.30
2024-06-30 $47k 14k 3.50
2021-12-31 $179k 20k 9.03
2019-12-31 $881k 38k 23.49

More positions owned by Aigen Investment Management

Microsoft Corporation (MSFT)
Blackrock (BLK)
Procter & Gamble Company (PG)
Amazon (AMZN)
Netflix (NFLX)
Key (KEY)
Icici Bank Adr (IBN)
Motorola Solutions Com New (MSI)
NVIDIA Corporation (NVDA)
Veeva Sys Cl A Com (VEEV)
Huntington Bancshares Incorporated (HBAN)
EOG Resources (EOG)
Kinder Morgan (KMI)
Automatic Data Processing (ADP)
Linde SHS (LIN)

View all positions for Aigen Investment Management

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
Adage Capital Partners GP
BlackRock
Vanguard Group
Velan Capital Investment Management
Palisade Capital Management
Tang Capital Management
Tejara Capital
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
JW Asset Management
D. E. Shaw & Co
Congress Park Capital

View all funds holding Heron Therapeutics